Whether you're an investor, healthcare provider, research institution, or talented engineer — we want to hear from you.
Our engineering team will walk you through the complete system — live biomarker readings from the Sensor Pro, algorithm explanation, clinical accuracy data review, and Q&A with our Chief Science Officer.
iGlutek's seed round is open to strategic investors with healthcare, MedTech, or AI backgrounds. We are not looking for passive capital — we seek partners who can open doors to clinical networks, regulatory advisors, and distribution channels.